Implementation of COVID-19 Testing Strategies in Community Health Centers
Study Details
Study Description
Brief Summary
This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: RADx CHCs testing intervention strategy Six Massachusetts community health center partnerships implementing both a common testing expansion implementation strategy plus tailored strategies designed for community partner needs. |
Other: RADx CHCs testing intervention strategy
The study team will support partner CHCs to implement workflows with some combination of dedicated testing staff, off-site testing, outreach/communications to priority populations, and linkage with local contact tracing systems. Implementation support will take the form of practice facilitation, rapid cycle testing (by supporting CHCs to review their internal data to assess the impact of workflow changes), and expert consultation from the research team on testing technology and testing location design.
|
Other: Usual care control
|
Other: Usual care control
CHCs implement testing strategies in accordance with their usual supports.
|
Outcome Measures
Primary Outcome Measures
- Percentage change in testing during the study compared to tests completed prior to study start [Months 1-9 post-implementation compared to 9 months pre-implementation]
Using a controlled interrupted time series design, comparing number of tests across the participating CHCs with matched control CHCs in MA
Eligibility Criteria
Criteria
Inclusion Criteria:
- Participants are patients at the intervention or control CHCs or members of the local community. The participating sites constitute one group; a set of matched control CHCs that will conduct testing as usual constitute the second group.
Exclusion Criteria:
- None
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Massachusetts League of Community Health Centers | Boston | Massachusetts | United States | 02108 |
2 | Massachusetts General Hospital | Boston | Massachusetts | United States | 02114 |
Sponsors and Collaborators
- Massachusetts General Hospital
- Dana-Farber Cancer Institute
- Harvard School of Public Health (HSPH)
- Massachusetts League of Community Health Centers
Investigators
- Principal Investigator: Elsie Taveras, MD, MPH, Massachusetts General Hospital
- Principal Investigator: Karen Emmons, PhD, Harvard School of Public Health (HSPH)
- Principal Investigator: Susan Dargon-Hart, LICSW, Massachusetts League of Community Health Centers
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020P003743